The average time for diagnosis in women is approximately 9 years'.
During this time they might see any number of physicians and undergo
numerous tests and examinations before a diagnosis, which sometimes
requires surgery, is made.
New technology now allows women suffering from endometriosis to benefit
from an early diagnosis.
A French team of experts specialising in endometriosis has recently
developed a saliva based diagnostic test that uses Next Generation
Sequencing of microRNA's with AI.
This non-invasive test, called Ziwig Endotest®, allows for the early detection of all types of endometriosis with a performance that exceeds that of conventional diagnostic.
>97%
SENSITIVITY>93%
SPECIFICITY
The Ziwig Endotest® is indicated for the diagnosis of endometriosis for female patients between the ages of 18 and 43 years who are clinically suspected to have endometriosis. The test is taken through a saliva sample.
NON-INVASIVE
A simple saliva sample –
no surgery required.
ADVANCED TECHNOLOGY
Uses microRNA sequencing
combined with AI.
RESULTS IN 5 WEEKS
Receive your results in
approximately 5 weeks.
IS THIS TEST SUITABLE FOR ME?
The Ziwig Endotest® is suitable for women aged 18–43 years who are clinically suspected of having endometriosis.
COMMON SYMPTOMS INCLUDE:
- Painful periods
- Chronic pelvic pain
- Pain during or after intercourse
- Pain when opening your bowels or passing urine during your period
- Heavy or irregular periods
- Bloating and digestive symptoms linked to your menstrual cycle
- Difficulty conceiving
HOW IT WORKS
INITIAL CONSULTATION
Meet with one of our experienced clinicians to discuss your symptoms and determine whether the test is appropriate.
SALIVA COLLECTION
A simple saliva sample is collected in clinic.
LABORATORY ANALYSIS
Your sample is analysed using advanced genomic technology.
REVIEW OF RESULTS
Results are available in approximately 5 weeks, after which one of our clinicians will discuss your report and any recommended next steps.
PRICING
Ziwig Endotest®
Fast appointments
available
